Diseases caused by human papillomavirus (HPV), such as cervical cancer, may have a new treatment option thanks to a technology developed by researchers at Imunotera Soluções Terapêuticas, a São Paulo startup incubated at Eretz.bio, the biotechnology startup hub at Albert Einstein Jewish Brazilian Hospital.
Go to Source
https://medicalxpress.com/rss-feed/